POAI Predictive Oncology
- 0.9378
- +0.0700+8.07%
- 0.9380
- +0.0002+0.02%
Predictive Oncology News
Predictive Oncology | D: Filing D
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-Director CHUNG-WELCH NANCY
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-Director HANDLEY DANIEL E
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-Director Nuzum Charles Lee Sr
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-Director Rao Veena
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-Director Hawryluk Matthew
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-Director ST. CLAIR GREGORY SR
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-Director Rao Veena
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-Director HANDLEY DANIEL E
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-Director ST. CLAIR GREGORY SR
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-Director CHUNG-WELCH NANCY
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-Director Hawryluk Matthew
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-Director Nuzum Charles Lee Sr
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-CHIEF FINANCIAL OFFICER MYERS ROBERT L
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-Director Nuzum Charles Lee Sr
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-Director Nuzum Charles Lee Sr
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-Director ST. CLAIR GREGORY SR
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-Director Rao Veena
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-Director Hawryluk Matthew
Predictive Oncology | 4: Statement of changes in beneficial ownership of securities-Director HANDLEY DANIEL E
Analysis
Price Target
No Data
